The role of the π–π stacking distance and abundance in the conductivity of PEDOT:PSS thin films and a new morphology are unraveled.

The development of low-Platinum content polymer electrolyte fuel cells (PEFCs) has been hindered by inexplicable reduction of oxygen reduction reaction (ORR) activity and unexpected O2 mass transport resistance when catalysts have been interfaced with ionomer in a cathode catalyst layer. In this study, we introduce a bottom-up designed spherical carbon support with intrinsic Nitrogen-doping that permits uniform dispersion of Pt catalyst, which reproducibly exhibits high ORR mass activity of 638 ± 68 mA mgPt−1 at 0.9 V and 100% relative humidity (RH) in a membrane electrode assembly. The uniformly distributed Nitrogen-functional surface groups on the carbon support surface promote high ionomer coverage directly evidenced by high-resolution electron microscopy and nearly humidity-independent double layer capacitance. The hydrophilic nature of the carbon surface appears to ensure high activity and performance for operation over a broad range of RH. The paradigm challenging large carbon support (~135 nm) combined with favourable ionomer film structure, hypothesized recently to arise from the interactions of an ionic moiety of the ionomer and Nitrogen-functional group of the catalyst support, results in an unprecedented low local oxygen transport resistance (5.0 s cm−1) for ultra-low Pt loading (34 ± 2 μgPt cm−2) catalyst layer.

Glial fibrillary acidic protein (GFAP) is as an intermediate filament protein expressed by certain cells in the central nervous system (CNS). GFAP has been recognized as a reliable biomarker of CNS injury. However, due to the absence of rapid and easy-to-use assays for the detection of CNS injury biomarkers, measuring GFAP levels to identify CNS injury has not attained widespread clinical implementation. In the present work, we developed a polyethylenimine (PEI) coated graphene screen-printed electrode and used it for highly sensitive immunosensing of GFAP. Covalent binding of GFAP antibody to the PEI-modified electrode surface along with electrochemical impedance spectroscopy was used for detecting the change in the electrical conductivity of the electrodes. A highly linear response was recorded for various GFAP concentrations. Quantitative, selective, and label-free detection was achieved in the dynamic range of 1 pg mL to 100 ng mL for GFAP spiked in phosphate buffer saline, artificial cerebrospinal fluid, and human blood serum. The performance of the immunosensor was further validated and correlated by testing samples with the commercially available enzyme-linked immunosorbent assay method. This functionalized electrode could be used clinically for rapid detection and monitoring of CNS injury.

The conceptualization of body-on-a-chip in 2004 resulted in a new approach for studying human physiology in three-dimensional culture. Despite pioneering works and the progress made in replicating human physiology on-a-chip, the stability, reliability, and preservation of cell-culture-treated microfluidic chips remain a challenge. The development of a reliable surface treatment technique to more efficiently and reproducibly modify microfluidic channels would significantly simplify the process of creating and implementing organ-on-a-chip (OOC) systems. In this work, a new flow-based coating technique using bioinspired polymers was implemented to create reliable, reproducible, ready-to-use microfluidic cell culture chips for OOC studies. Single-channel polydimethylsiloxane microfluidic chips were coated with the bioinspired catecholamine polymers, polydopamine (PDA) and polynorepinephrine (PNE), using a flow-based coating technique. The functionality of the resulting microfluidic chips was evaluated by extensive surface characterizations, at 130 °C, in the presence of various cleaning and culture media in static and flow conditions regularly used in OOCs and tested for shelf life by storing the coated microfluidic chips for 4 months at room temperature. Microfluidic chips coated with polycatecholamine were then seeded with the mouse cancer cell line Cath.a.differentiated (CAD) and with the normal human cerebral microvascular endothelial cell line human cerebral microvascular endothelial cells (hCMEC)/D3. Cell viability, cell phenotype, and cell functionality were assessed to evaluate the performance of both the coatings and the surface treatment technique. Both PDA- and PNE-coated microfluidic chips maintained high viability, phenotype, and functionality of CAD cells and hCMEC/D3 cells. In addition, CAD cells retained high viability when they were cultured in both the polymer-coated chips, which were stored at room temperature for up to 120 days. These results suggest that flow-based techniques to coat surfaces with polycatecholamines can be used to generate ready-to-use microfluidic OOC chips that offer long-term stability and reliability for the culture of cell types with application in pathophysiological studies and drug screening.